We are live on ! Find out more
JIC

Joel Isaacson & Co Portfolio holdings

AUM $3.02B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+21.81%
3 Year Est. Return
+61.27%
5 Year Est. Return
+65.83%
10 Year Est. Return
+229.48%
AUM
$298M
AUM Growth
+$22.6M
Cap. Flow
+$19M
Cap. Flow %
6.38%
Top 10 Hldgs %
62.44%
Holding
613
New
99
Increased
85
Reduced
54
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 6.58%
2 Technology 4.63%
3 Financials 4.42%
4 Communication Services 4.12%
5 Consumer Staples 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
76
Walmart Inc
WMT
$909B
$341K 0.11%
13,404
TJX icon
77
TJX Companies
TJX
$171B
$334K 0.11%
11,000
RTX icon
78
RTX Corp
RTX
$261B
$328K 0.11%
4,456
+74
+2% +$5.32K
ORCL icon
79
Oracle
ORCL
$364B
$318K 0.11%
7,775
+3
+0% +$114
VBK icon
80
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$314K 0.11%
2,525
+2,000
+381% +$248K
EMR icon
81
Emerson Electric
EMR
$78.2B
$311K 0.1%
4,656
-151
-3% -$9.94K
ED icon
82
Consolidated Edison
ED
$41.4B
$309K 0.1%
5,766
-135
-2% -$7.32K
KMB icon
83
Kimberly-Clark
KMB
$36B
$309K 0.1%
2,928
+58
+2% +$6K
PLL
84
DELISTED
PALL CORP
PLL
$309K 0.1%
3,449
SLB icon
85
SLB Ltd
SLB
$70.3B
$297K 0.1%
3,050
PX
86
DELISTED
Praxair Inc
PX
$292K 0.1%
2,227
+6
+0.3% +$778
MGK icon
87
Vanguard Mega Cap Growth ETF
MGK
$32.7B
$290K 0.1%
+20,000
New +$289K
PBE icon
88
Invesco Biotechnology & Genome ETF
PBE
$285M
$287K 0.1%
+6,890
New +$295K
BX icon
89
Blackstone
BX
$155B
$279K 0.09%
8,550
+117
+1% +$3.73K
EPD icon
90
Enterprise Products Partners
EPD
$82.6B
$278K 0.09%
8,002
IYW icon
91
iShares US Technology ETF
IYW
$24B
$273K 0.09%
+12,000
New +$268K
KRFT
92
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$268K 0.09%
4,776
GNC
93
DELISTED
GNC Holdings, Inc.
GNC
$257K 0.09%
5,845
MDLZ icon
94
Mondelez International
MDLZ
$78.3B
$252K 0.08%
7,284
-390
-5% -$13.3K
HON icon
95
Honeywell
HON
$71.3B
$249K 0.08%
2,988
-721
-19% -$59.7K
XLNX
96
DELISTED
Xilinx Inc
XLNX
$244K 0.08%
4,500
BP icon
97
BP
BP
$108B
$242K 0.08%
6,138
-249
-4% -$9.82K
CLB icon
98
Core Laboratories
CLB
$523M
$238K 0.08%
1,200
P
99
DELISTED
Pandora Media Inc
P
$233K 0.08%
7,689
EEM icon
100
iShares MSCI Emerging Markets ETF
EEM
$28B
$230K 0.08%
5,600
+425
+8% +$16.7K

Similar funds

Joel Isaacson & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Joel Isaacson & Co held 613 positions worth $298M, up 8.2% from $275M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Joel Isaacson & Co deployed $19M of net new capital in Q1 2014, opening 99 new positions and adding to 85 existing holdings. Its largest new stake was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 6.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P International Dividend ETF, an estimated $524K trimmed.

  • Joel Isaacson & Co's largest Q1 2014 buy was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.
  • Joel Isaacson & Co added most to State Street SPDR S&P Dividend ETF in Q1 2014, an estimated $5.6M increase.
  • Joel Isaacson & Co's biggest Q1 2014 reduction was State Street SPDR S&P International Dividend ETF, cutting an estimated $524K.
  • Joel Isaacson & Co fully exited Vitamin Shoppe Inc. in Q1 2014, selling an estimated $676K.
  • Joel Isaacson & Co's ten largest holdings make up 62% of its $298M portfolio in Q1 2014.
  • Joel Isaacson & Co opened 99 new positions and closed 20 in Q1 2014.
  • Joel Isaacson & Co's portfolio value rose 8.2% quarter-over-quarter to $298M.

Based on Joel Isaacson & Co's 13F filing for Q1 2014, filed 11 Apr 2014.